Long-acting subcutaneous granisetron depot(Camurus)

N/A

Report date: 2025/08/19 14:10:03

Base Information

Drug NameLong-acting subcutaneous granisetron depot(Camurus)
Drug Alias NameCAM-2047CAM2047
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCamurus Ab
China Registration ClassN/A

Develop Information

Active CompaniesCamurus Ab
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A